BridgeMD
New treatment option for Medication Overuse Headache
Official title Personalized Pulsed Radiofrequency of the Greater Occipital Nerve for Medication Overuse Headache
ClinicalTrials.gov ID: NCT07360782
What this study is testing
- What it's testing
- This study evaluates a novel treatment approach for medication overuse headache (MOH) using greater occipital nerve pulsed radiofrequency (GONPRF). Three treatment strategies are compared: Standard Treatment: Limitation of overused acute headache medications, lifestyle counseling, and continuation of existing preventive medications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age 18-65 years
- Diagnosed with Medication Overuse Headache (MOH) according to ICHD-3 criteria
- No laboratory evidence of bleeding or clotting disorders
- No active infection
- Not pregnant and no suspicion of pregnancy
You likely can't join if
- Changes in preventive treatment for migraine and/or tension-type headache within the last 3 months
- Severe systemic disease (e.g., uncontrolled diabetes, serious cardiovascular disease, malignancy)
- Psychiatric disorders (including current antidepressant use or psychiatric follow-up)
- History of alcohol or substance abuse
- Pregnancy, breastfeeding, or plans for pregnancy in the next 12 months
- Concurrent use of other prophylactic headache treatments
See the full eligibility criteria
- Age 18-65 years
- Diagnosed with Medication Overuse Headache (MOH) according to ICHD-3 criteria
- No laboratory evidence of bleeding or clotting disorders
- No active infection
- Not pregnant and no suspicion of pregnancy
- No history of craniocervical surgery that may alter anatomical structures at the intervention site
- Able to understand the study procedures, provide written informed consent, and comply with treatment
- Changes in preventive treatment for migraine and/or tension-type headache within the last 3 months
- Severe systemic disease (e.g., uncontrolled diabetes, serious cardiovascular disease, malignancy)
- Psychiatric disorders (including current antidepressant use or psychiatric follow-up)
- History of alcohol or substance abuse
- Pregnancy, breastfeeding, or plans for pregnancy in the next 12 months
- Concurrent use of other prophylactic headache treatments
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.